FDA inspection
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical: FDA inspection ending Mar 23, 2017
FDA inspection 1005977 · Los Angeles, CA
Key facts
| Inspection ID | 1005977 |
|---|---|
| Firm | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical |
| FEI number | 3013341563 |
| Address | 1990 Westwood Blvd Ste 135 |
| City | Los Angeles |
| State | CA |
| ZIP | 90025-4650 |
| Fiscal year | 2017 |
| Inspection end date | Mar 23, 2017 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 546956 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data